$TRIL Trillium Therapeutics Inc. Insider Trading
Get free email notifications about insider trading in Trillium Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Trillium Therapeutics Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Trillium Therapeutics Inc. for free.
CIK Number: 0001616212
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TRIL
Company Address: 2488 DUNWIN DRIVE MISSISSAUGA L5L 1J9
Phone number: (416) 595-0627
Former name: Stem Cell Therapeutics Corp.
Former name: Neurogenesis Biotech Corp.
Trillium Therapeutics Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | TRIL | Trillium Therapeut ... | Skvarka Jan | President and CEO | Option Exercise | M | 0.31 | 23,802 | 7,474 | 197,000 | |
May 13 2021 | TRIL | Trillium Therapeut ... | Skvarka Jan | President and CEO | Option Exercise | M | 0.31 | 19,198 | 6,028 | 220,802 | |
May 13 2021 | TRIL | Trillium Therapeut ... | Skvarka Jan | President and CEO | Option Exercise | M | 0.45 | 87,500 | 39,043 | 1,162,500 | |
May 13 2021 | TRIL | Trillium Therapeut ... | Skvarka Jan | President and CEO | Sell | S | 9.24 | 23,802 | 219,880 | 0 | 23.8 K to 0 (-100.00 %) |
May 13 2021 | TRIL | Trillium Therapeut ... | Skvarka Jan | President and CEO | Buy | M | 0.31 | 23,802 | 7,474 | 23,802 | 0 to 23.8 K |
May 13 2021 | TRIL | Trillium Therapeut ... | Skvarka Jan | President and CEO | Sell | S | 9.20 | 106,698 | 981,803 | 0 | 106.7 K to 0 (-100.00 %) |
May 13 2021 | TRIL | Trillium Therapeut ... | Skvarka Jan | President and CEO | Buy | M | 0.31 | 19,198 | 6,028 | 106,698 | 87.5 K to 106.7 K (+21.94 %) |
May 13 2021 | TRIL | Trillium Therapeut ... | Skvarka Jan | President and CEO | Buy | M | 0.45 | 87,500 | 39,043 | 87,500 | 0 to 87.5 K |
May 11 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Option Exercise | M | 0.31 | 3,646 | 1,141 | 109,375 | |
May 11 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Sell | S | 9.30 | 3,646 | 33,908 | 0 | 3.6 K to 0 (-100.00 %) |
May 11 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Buy | M | 0.31 | 3,646 | 1,141 | 3,646 | 0 to 3.6 K |
May 05 2021 | TRIL | Trillium Therapeut ... | Looker Benjamin | General Counsel | Option Exercise | A | 9.51 | 190,000 | 1,806,900 | 190,000 | |
Apr 09 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Option Exercise | M | 0.30 | 3,646 | 1,098 | 113,021 | |
Apr 09 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Sell | S | 10.82 | 3,646 | 39,450 | 0 | 3.6 K to 0 (-100.00 %) |
Apr 09 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Buy | M | 0.30 | 3,646 | 1,098 | 3,646 | 0 to 3.6 K |